Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis
J. Das*, J. A. Snowden, J. Burman, M. S. Freedman, H. Atkins, M. Bowman, R. K. Burt, R. Saccardi, C. Innocenti, S. Mistry, P. J. Laud, H. Jessop, B. Sharrack
Dive into the research topics of 'Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis'. Together they form a unique fingerprint.